| pubmed-article:1524170 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1524170 | lifeskim:mentions | umls-concept:C0019994 | lld:lifeskim |
| pubmed-article:1524170 | lifeskim:mentions | umls-concept:C0007020 | lld:lifeskim |
| pubmed-article:1524170 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
| pubmed-article:1524170 | lifeskim:mentions | umls-concept:C0809949 | lld:lifeskim |
| pubmed-article:1524170 | lifeskim:mentions | umls-concept:C1707491 | lld:lifeskim |
| pubmed-article:1524170 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:1524170 | pubmed:dateCreated | 1992-10-13 | lld:pubmed |
| pubmed-article:1524170 | pubmed:abstractText | A longitudinal study of one hundred consecutive admissions to the Royal Adelaide Hospital for carbon monoxide poisoning was conducted from 1986 to 1989. Twenty-five patients left hospital with persistent symptoms and signs of this poisoning. Five subsequently recovered. Twenty-four other patients, who were well when they left hospital, did not attend for a review one month after discharge. Extensive neuropsychiatric testing at this time showed 32% (24 of 76) had obvious sequelae of their exposure. Overall, the frequency of neuropsychiatric sequelae in the patients who only received oxygen at atmospheric pressure was 63% (N = 8) on discharge and 67% (N = 6) on one month follow-up. The frequency of sequelae among those who were given one hyperbaric oxygen treatment only was 46% (N = 24) on discharge and 50% (N = 20) on one month follow-up. In contrast, the frequency of sequelae in patients who had two or more hyperbaric oxygen treatments was only 13% (N = 68) on discharge (P less than 0.005) and 18% (N = 50) on follow-up (P less than 0.005). the frequency of sequelae was also significantly greater if hyperbaric oxygen was delayed (P less than 0.05). No markers of severe poisoning could be identified. | lld:pubmed |
| pubmed-article:1524170 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1524170 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1524170 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1524170 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1524170 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1524170 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:1524170 | pubmed:issn | 0310-057X | lld:pubmed |
| pubmed-article:1524170 | pubmed:author | pubmed-author:VEISJJ | lld:pubmed |
| pubmed-article:1524170 | pubmed:author | pubmed-author:ClaytonDD | lld:pubmed |
| pubmed-article:1524170 | pubmed:author | pubmed-author:GilliganJ EJE | lld:pubmed |
| pubmed-article:1524170 | pubmed:author | pubmed-author:GormanD FDF | lld:pubmed |
| pubmed-article:1524170 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1524170 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:1524170 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1524170 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1524170 | pubmed:pagination | 311-6 | lld:pubmed |
| pubmed-article:1524170 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:1524170 | pubmed:meshHeading | pubmed-meshheading:1524170-... | lld:pubmed |
| pubmed-article:1524170 | pubmed:meshHeading | pubmed-meshheading:1524170-... | lld:pubmed |
| pubmed-article:1524170 | pubmed:meshHeading | pubmed-meshheading:1524170-... | lld:pubmed |
| pubmed-article:1524170 | pubmed:meshHeading | pubmed-meshheading:1524170-... | lld:pubmed |
| pubmed-article:1524170 | pubmed:meshHeading | pubmed-meshheading:1524170-... | lld:pubmed |
| pubmed-article:1524170 | pubmed:meshHeading | pubmed-meshheading:1524170-... | lld:pubmed |
| pubmed-article:1524170 | pubmed:meshHeading | pubmed-meshheading:1524170-... | lld:pubmed |
| pubmed-article:1524170 | pubmed:meshHeading | pubmed-meshheading:1524170-... | lld:pubmed |
| pubmed-article:1524170 | pubmed:meshHeading | pubmed-meshheading:1524170-... | lld:pubmed |
| pubmed-article:1524170 | pubmed:meshHeading | pubmed-meshheading:1524170-... | lld:pubmed |
| pubmed-article:1524170 | pubmed:meshHeading | pubmed-meshheading:1524170-... | lld:pubmed |
| pubmed-article:1524170 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1524170 | pubmed:articleTitle | A longitudinal study of 100 consecutive admissions for carbon monoxide poisoning to the Royal Adelaide Hospital. | lld:pubmed |
| pubmed-article:1524170 | pubmed:affiliation | Department of Anaesthesia and Intensive Care, Royal Adelaide Hospital, New Zealand. | lld:pubmed |
| pubmed-article:1524170 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1524170 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1524170 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1524170 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1524170 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1524170 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1524170 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1524170 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1524170 | lld:pubmed |
